{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:24:13Z","timestamp":1791321853026,"version":"4.3.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1084276"],"award-info":[{"award-number":["OPP1084276"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Math Biol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11538-024-01285-1","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T10:02:14Z","timestamp":1714039334000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Mathematical Model for the Impact of 3HP and Social Programme Implementation on the Incidence and Mortality of Tuberculosis: Study in Brazil"],"prefix":"10.1007","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5937-5374","authenticated-orcid":false,"given":"Erick Manuel","family":"Delgado Moya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Alejandro","family":"Ordo\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Alves Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Niskier Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robson Bruniera","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Volmir Anderle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Rasella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,25]]},"reference":[{"key":"1285_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1371\/journal.pgph.0000017","volume":"117","author":"GG Alvarez","year":"2022","unstructured":"Alvarez GG, Sullivan K, Pease C, Dyk DV, Mallick R et al (2022) Effect of implementation of a 12-dose once-weekly treatment (3HP) in addition to standard regimens to prevent TB on completion rates: Interrupted time series design. Int J Infect Dis 117:222\u2013229. https:\/\/doi.org\/10.1371\/journal.pgph.0000017","journal-title":"Int J Infect Dis"},{"key":"1285_CR2","unstructured":"Attanasio O, Gomez LC, Heredia P, Vera-Hernandez M (2016) The short-term impact of a conditional cash subsidy on child health and nutrition in Colombia. https:\/\/www.ifs.org.uk\/publications\/350. Accessed 16 Oct 2022"},{"key":"1285_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182336","volume":"12","author":"ML Bastos","year":"2017","unstructured":"Bastos ML, Menzies D, Hone T, Dehghani K, Trajman A (2017) The impact of the Brazilian family health strategy on selected primary care sensitive conditions: a systematic review. PLoS ONE 12:e0182336. https:\/\/doi.org\/10.1371\/journal.pone.0182336","journal-title":"PLoS ONE"},{"key":"1285_CR4","doi-asserted-by":"crossref","unstructured":"Borisov AS, Morris SB, Njie GJ, Winston CA, et al. (2018) Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection. MMWR Morb Mortal Wkly Rep 67(25), 723\u2013726. https:\/\/doi.org\/10.15585\/mmwr.mm6725a5","DOI":"10.15585\/mmwr.mm6725a5"},{"key":"1285_CR5","unstructured":"Brasil Ministo da Sade. Secretaria de Vigilia em Sade. Departamento de Vigilia Epidemiola (2011) Manual de Recomendas para o controle da Tuberculose no Brasil. Brasa: Ministo da Sade. https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_recomendacoes_controle_tuberculose_brasil_2_ed.pdf. Accessed 10 nov 2022"},{"key":"1285_CR6","unstructured":"Brasil Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Vigil\u00e2ncia Epidemiol\u00f3gica (2011) Manual de Recomenda\u00e7\u00f5es para o controle da Tuberculose no Brasil. Brasil: Minist\u00e9rio da Sa\u00fade. https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/manual_recomendacoes_controle_tuberculose_brasil_2_ed.pdf Accessed 10 nov 2022"},{"key":"1285_CR7","doi-asserted-by":"publisher","unstructured":"Chatzilena A, van Leeuwen E, Ratmann O, Baguelin M, Demiris N (2019) Contemporary statistical inference for infectious disease models using Stan. Epidemic 29. https:\/\/doi.org\/10.1016\/j.epidem.2019.100367","DOI":"10.1016\/j.epidem.2019.100367"},{"key":"1285_CR8","unstructured":"Departamento de Doen\u00e7as de Condi\u00e7oes Cr\u00f4nicas e Infe\u00e7coes Sexualmente Transmiss\u00edveis (2020) Boletim Epidemiol\u00f3gico de Turbeculose 2020. http:\/\/www.aids.gov.br\/pt-br\/pub\/2020\/boletim-epidemiologico-de-turbeculose-2020. Accessed 16 Oct 2022"},{"key":"1285_CR9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01128-2018","author":"G Froberg","year":"2019","unstructured":"Froberg G, Jansson L, Bruchfeld J (2019) Treatment of latent tuberculosis with 12 weeks isoniazid\/rifapentine in clinical practice. Eur Respir. https:\/\/doi.org\/10.1183\/13993003.01128-2018","journal-title":"Eur Respir"},{"key":"1285_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-10447-y","volume":"10","author":"M Gabriela","year":"2019","unstructured":"Gabriela M, Gomes M, Oliveira JF, Bertolde A, Ayabina D, Nguyen TA et al (2019) Introducing risk inequality metrics in tuberculosis policy development. Nat Commun 10:1\u201312. https:\/\/doi.org\/10.1038\/s41467-019-10447-y","journal-title":"Nat Commun"},{"issue":"8","key":"1285_CR11","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1590\/1806-3713\/e20190023","volume":"36","author":"G Garziera","year":"2017","unstructured":"Garziera G, Morsch ALB, Otesbelgue F, Staub FL, Palominos PE, Brenol CV, Silva DR (2017) Latent tuberculosis infection and tuberculosis in patients with rheumatic diseases treated with anti-tumor necrosis factor agents. Clin Rheumatol 36(8):1891\u20131896. https:\/\/doi.org\/10.1590\/1806-3713\/e20190023","journal-title":"Clin Rheumatol"},{"issue":"4","key":"1285_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2307\/1266199","volume":"9","author":"R Gnanadesikan","year":"2007","unstructured":"Gnanadesikan R, Pinkham RS, Hughes LP (2007) Maximum likelihood estimation of the parameters of the beta distribution from smallest order statistics. Technometrics 9(4):607\u2013620. https:\/\/doi.org\/10.2307\/1266199","journal-title":"Technometrics"},{"key":"1285_CR13","doi-asserted-by":"crossref","unstructured":"Haley CA (2017) Treatment of latent tuberculosis infection. Microbiol Spectr 5. https:\/\/doi.org\/10.1128\/MICROBIOLSPEC.TNMI7-0039-2016","DOI":"10.1128\/microbiolspec.TNMI7-0039-2016"},{"issue":"12","key":"1285_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000017","volume":"1","author":"A Heyd","year":"2021","unstructured":"Heyd A, Heffernan C, Storey K, Wild TC, Long R (2021) Treating latent tuberculosis infection (LTBI) with isoniazid and rifapentine (3HP) in an inner-city population with psychosocial barriers to treatment adherence: A qualitative descriptive study. PLOS Glob Public Health 1(12):e0000017. https:\/\/doi.org\/10.1371\/journal.pgph.0000017","journal-title":"PLOS Glob Public Health"},{"key":"1285_CR15","doi-asserted-by":"publisher","unstructured":"Hoffman JIE (2015) Chapter 20 - Some epidemiological considerations: odds ratio, relative risk, and attributable risk. Biostatistics for Medical and Biomedical Practitioners. Academic Press, 287-306, ISBN: 978-0-12-802387-7. https:\/\/doi.org\/10.1016\/B978-0-12-802387-7.00020-2","DOI":"10.1016\/B978-0-12-802387-7.00020-2"},{"key":"1285_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S2214-109X(18)30478-9","volume":"10","author":"R Hoffmann","year":"2008","unstructured":"Hoffmann R, Ney MG (2008) The recent fall in income inequality in Brazil: analysis of PNAD data, demographic censuses and national accounts. Economica 10:7\u201339. https:\/\/doi.org\/10.1016\/S2214-109X(18)30478-9","journal-title":"Economica"},{"key":"1285_CR17","unstructured":"IBGE (2022) Proje\u00e7\u00f5es da popula\u00e7\u00e3o. https:\/\/www.ibge.gov.br\/apps\/populacao\/projecao\/index.html. Accessed 15 oct 2022"},{"issue":"3","key":"1285_CR18","doi-asserted-by":"publisher","first-page":"E390","DOI":"10.1016\/S2214-109X(21)00550-7","volume":"10","author":"GS Jesus","year":"2022","unstructured":"Jesus GS, Pescarini JM, Silva AF, Torrens A, Carvalho WM et al (2022) The effect of primary health care on tuberculosis in a nationwide cohort of 7.3 million Brazilian people: a quasi-experimental study. Technometrics 10(3):E390\u2013E397. https:\/\/doi.org\/10.1016\/S2214-109X(21)00550-7","journal-title":"Technometrics"},{"issue":"1","key":"1285_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4046\/trd.2017.0052","volume":"81","author":"HW Kim","year":"2018","unstructured":"Kim HW, Kim JS (2018) Treatment of latent tuberculosis infection and its clinical efficacy. Tuberc Respir Dis (Seoul) 81(1):6\u201312. https:\/\/doi.org\/10.4046\/trd.2017.0052","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"1285_CR20","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1017\/S0007114516000714","volume":"115","author":"S Lopez-Arana","year":"2016","unstructured":"Lopez-Arana S, Avendano M, Forde I, van Lenthe I et al (2016) Conditional cash transfers and the double burden of malnutrition among children in Colombia: a quasi-experimental study. Br J Nutr 115:1780\u20131789. https:\/\/doi.org\/10.1017\/S0007114516000714","journal-title":"Br J Nutr"},{"issue":"11","key":"1285_CR21","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.5588\/ijtld.18.0035","volume":"22","author":"MM Macaraig","year":"2018","unstructured":"Macaraig MM, Jalees M, Lam C, Burzynski J (2018) Improved treatment completion with shorter treatment regimens for latent tuberculous infection. Int J Tuberc Lung Dis 22(11):1344\u20131349. https:\/\/doi.org\/10.5588\/ijtld.18.0035","journal-title":"Int J Tuberc Lung Dis"},{"key":"1285_CR22","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1183\/09031936.00120908","volume":"33","author":"U Mack","year":"2009","unstructured":"Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D (2009) LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 33:956\u2013973. https:\/\/doi.org\/10.1183\/09031936.00120908","journal-title":"Eur Respir J"},{"key":"1285_CR23","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.1284264","author":"C Margossian","year":"2017","unstructured":"Margossian C, Gillespie B (2017) Differential equation-based models in stan. J Pharmacokinet Pharmacodyn. https:\/\/doi.org\/10.5281\/zenodo.1284264","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"1285_CR24","unstructured":"Minist\u00e9rio da Sa\u00fade. (2022) Tratamento mais eficiente no SUS beneficia pacientes com tuberculose. https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/noticias\/2022\/fevereiro\/tratamento-mais-eficiente-no-sus-beneficia-pacientes-com-tuberculose#::text=O%20SUS%20oferece%20tr%C3%AAs%20esquemas,quatro%20meses%20(120%20doses). Accessed 15 Nov 2022"},{"key":"1285_CR25","unstructured":"Minist\u00e9rio do Desenvolvimento. Social e Combate \u00e1 Fome (2015) Bolsa Familia: como funciona. Assist\u00eancia Social. http:\/\/mds.gov.br\/assuntos\/bolsafamilia\/o-que-e\/como-funciona. Accessed 10 Nov 2022"},{"key":"1285_CR26","unstructured":"Minist\u00e9rio do Desenvolvimento. Social e Combate \u00e1 Fome. Secretaria Nacional de Renda de Cidadania (2013) Programa Bolsa Fama: umadecada de inclusao e cidadania. http:\/\/www.ipea.gov.br\/portal\/images\/stories\/PDFs\/livros\/livros\/livro_bolsafamilia_10anos.pdf. Accessed 10 Nov 2022"},{"issue":"3","key":"1285_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213524","volume":"14","author":"N Nwana","year":"2019","unstructured":"Nwana N, Marks SM, Lan E, Chang AH, Holcombe M, Morris SB (2019) Treatment of latent Mycobacterium tuberculosis infection with 12 once weekly directly-observed doses of isoniazid and rifapentine among persons experiencing homelessness. PLoS ONE 14(3):e0213524. https:\/\/doi.org\/10.1371\/journal.pone.0213524","journal-title":"PLoS ONE"},{"key":"1285_CR28","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1016\/S2214-109X(18)30478-9","volume":"7","author":"JGN Oliosi","year":"2019","unstructured":"Oliosi JGN, Reis-Santos B, Locatelli RL, Sales CMM, Silva Filho WC et al (2019) Effect of the Bolsa Familia Programme on the outcome of tuberculosis treatment: a prospective cohort study. Lancet Glob Health 7:e219-26. https:\/\/doi.org\/10.1016\/S2214-109X(18)30478-9","journal-title":"Lancet Glob Health"},{"key":"1285_CR29","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(11)60054-8","volume":"377","author":"J Paim","year":"2011","unstructured":"Paim J, Travassos C, Almeida Bahia L, Macinko J (2011) The Brazilian health system: history, advances, and challenges. Lancet 377:1778\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(11)60054-8","journal-title":"Lancet"},{"issue":"1","key":"1285_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2307\/2334123","volume":"28","author":"K Pearson","year":"1936","unstructured":"Pearson K (1936) Method of moments and method of maximum likelihood. Biometrika 28(1):34\u201359. https:\/\/doi.org\/10.2307\/2334123","journal-title":"Biometrika"},{"issue":"6","key":"1285_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/pds.4423","volume":"27","author":"C Pease","year":"2018","unstructured":"Pease C, Hutton B, Yazdi F, Wolfe D, Hamel C, Barbeau P, Skidmore B, Alvarez GG (2018) A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection. Pharmacoepidemiol Drug Saf 27(6):557\u2013566. https:\/\/doi.org\/10.1002\/pds.4423","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1285_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.econedurev.2009.07.005","volume":"29","author":"J Ponce","year":"2010","unstructured":"Ponce J, Bedi AS (2010) The impact of a cash transfer program on cognitive achievement: the Bono de Desarrollo humano of ecuador. Econ Educ Rev 29(1):116\u2013125. https:\/\/doi.org\/10.1016\/j.econedurev.2009.07.005","journal-title":"Econ Educ Rev"},{"key":"1285_CR33","doi-asserted-by":"crossref","unstructured":"Rangaka MX, Hamada Y, Duong T, Bern H, Calvert J, et al. (2022) Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an openlabel, multicentre, randomised controlled trial. BMJ Open 12: e057717. https:\/\/doi.org\/bmjopen-2021-057717","DOI":"10.1136\/bmjopen-2021-057717"},{"key":"1285_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1214\/154957804100000024","volume":"1","author":"GO Roberts","year":"2004","unstructured":"Roberts GO, Rosenthal JS (2004) General state space Markov chains and MCMC Algorithms. J Pharmacokinet Pharmacodyn 1:20\u201371. https:\/\/doi.org\/10.1214\/154957804100000024","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"7","key":"1285_CR35","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/cid\/cix505","volume":"65","author":"AL Sandul","year":"2017","unstructured":"Sandul AL, Nwana N, Holcombe JM, Lobato MN, Marks S et al (2017) High rate of treatment completion in program settings with 12-dose weekly isoniazid and rifapentine for latent mycobacterium tuberculosis infection. Clin Infect Dis 65(7):1085\u20131093. https:\/\/doi.org\/10.1093\/cid\/cix505","journal-title":"Clin Infect Dis"},{"key":"1285_CR36","doi-asserted-by":"publisher","unstructured":"Santos MLSG, Vendramini SHF, Gazetta CE, Oliveira SAC, Villa TCS (2007) Pobreza: caracteriza\u00e7\u00e3o socioecon\u00f4mica da tuberculose. Rev Latino Am Enfermagem 15:762\u2013767. https:\/\/doi.org\/10.1590\/S0104-11692007000700008","DOI":"10.1590\/S0104-11692007000700008"},{"issue":"1","key":"1285_CR37","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/s12879-018-3468-z","volume":"18","author":"YL Schein","year":"2018","unstructured":"Schein YL, Madebo T, Andersen HE, Arnesen TM, Dyrhol-Riise AM, Tveiten H, White RA, Winje BA (2018) Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study. BMC Infect Dis 18(1):587. https:\/\/doi.org\/10.1186\/s12879-018-3468-z","journal-title":"BMC Infect Dis"},{"issue":"2","key":"1285_CR38","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1097\/PHH.0000000000000822","volume":"25","author":"KM Schmit","year":"2019","unstructured":"Schmit KM, Lobato MN, Lang SG, Wheeler S, Kendig NE, Bur S (2019) High completion rate for 12 weekly doses of isoniazid and rifapentine as treatment for latent mycobacterium tuberculosis infection in the federal bureau of prisons. J Public Health Manag Pract 25(2):E1\u2013E6. https:\/\/doi.org\/10.1097\/PHH.0000000000000822","journal-title":"J Public Health Manag Pract"},{"key":"1285_CR39","doi-asserted-by":"publisher","unstructured":"- Silva SYB, Pinto SG, Medeiros ER, Reboucas DGC, Paiva ACS et al (2019) Estrat\u00e9gias de avalia\u00e7\u00e3o das interven\u00e7\u00f5es para o controle de tuberculose: revis\u00e3o integrativa. Rev. Bras. Enferm. https:\/\/doi.org\/10.1590\/0034-7167-2017-0922","DOI":"10.1590\/0034-7167-2017-0922"},{"key":"1285_CR40","unstructured":"Sistema de salud de Ecuador (2019) The short-term impact of a conditional cash subsidy on child health and nutrition in Colombia. http:\/\/www.scielo.org.mx\/scielo.php?script=sci_arttext &pid=S0036-36342011000800013. Accessed 12 Oct 2022"},{"key":"1285_CR41","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F et al (2011) Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection. N Engl J Med 365:2155\u20132166. https:\/\/doi.org\/10.1056\/NEJMoa1104875","journal-title":"N Engl J Med"},{"issue":"23","key":"1285_CR42","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling TR, Villarino ME, Borisov AS, Shang N et al (2011) Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 365(23):2155\u20132166. https:\/\/doi.org\/10.1056\/NEJMoa1104875","journal-title":"N Engl J Med"},{"key":"1285_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.tube.2018.05.013","volume":"111","author":"HY Sun","year":"2018","unstructured":"Sun HY, Huang YW, Huang WC, Chang LY, Chan PC et al (2018) Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan. Tuberculosis (Edinb) 111:121\u2013126. https:\/\/doi.org\/10.1016\/j.tube.2018.05.013","journal-title":"Tuberculosis (Edinb)"},{"key":"1285_CR44","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s40506-017-0135-7","volume":"9","author":"P Tang","year":"2017","unstructured":"Tang P, Johnston J (2017) Treatment of latent tuberculosis infection. Curr Treat Options Infect Dis 9:371\u2013379. https:\/\/doi.org\/10.1007\/s40506-017-0135-7","journal-title":"Curr Treat Options Infect Dis"},{"key":"1285_CR45","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1472-6963-10-297","volume":"10","author":"I Vargas","year":"2010","unstructured":"Vargas I, Vazquez ML, Mogollon-Perez AD (2010) Unger JP (2010) Barriers of access to care in a managed competition model: lessons from Colombia. BMC Health Serv Res 10:297. https:\/\/doi.org\/10.1186\/1472-6963-10-297","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"1285_CR46","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","volume":"169","author":"ME Villarino","year":"2018","unstructured":"Villarino ME, Scott NA, Weis SE, Weiner M et al (2018) Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr 169(3):247\u2013255. https:\/\/doi.org\/10.1001\/jamapediatrics.2014.3158","journal-title":"JAMA Pediatr"},{"key":"1285_CR47","volume-title":"Introduction to probability and random variables","author":"GP Wadsworth","year":"1960","unstructured":"Wadsworth GP (1960) Introduction to probability and random variables. McGraw-Hill, New York"},{"key":"1285_CR48","unstructured":"WHO (2018) Global tuberculosis report 2018. https:\/\/apps.who.int\/iris\/handle\/10665\/274453. Accessed 15 Oct 2022"},{"key":"1285_CR49","unstructured":"WHO (2022) Tuberculosis. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis. Accessed 15 nov 2022"}],"container-title":["Bulletin of Mathematical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-024-01285-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11538-024-01285-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-024-01285-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T09:19:23Z","timestamp":1716369563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11538-024-01285-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,25]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1285"],"URL":"https:\/\/doi.org\/10.1007\/s11538-024-01285-1","relation":{},"ISSN":["0092-8240","1522-9602"],"issn-type":[{"value":"0092-8240","type":"print"},{"value":"1522-9602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,25]]},"assertion":[{"value":"8 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"61"}}